SYSTEMATIC REVIEW article

Front. Neurol., 12 January 2026

Sec. Stroke

Volume 16 - 2025 | https://doi.org/10.3389/fneur.2025.1682671

Network meta-analysis of different electrical stimulation therapies for lower limb functional rehabilitation in stroke patients

  • The First Affiliated Hospital of Hunan College of Traditional Chinese Medicine, Hunan Province Directly Affiliated TCM Hospital, Zhuzhou, China

Article metrics

View details

911

Views

86

Downloads

Abstract

Introduction:

Electrical stimulation is widely applied in the rehabilitation of post-stroke lower limb dysfunction; however, its comparative efficacy and safety across different modalities remain unclear. Substantial heterogeneity among electrical stimulation techniques limits evidence-based clinical decision-making, highlighting the need for a comprehensive comparative evaluation.

Methods:

A comprehensive literature search was conducted across seven databases (CNKI, Wanfang, VIP, PubMed, Embase, Web of Science, and the Cochrane Library) from inception to June 2025. Randomized controlled trials evaluating electrical stimulation interventions for post-stroke lower limb dysfunction were included. Methodological quality was assessed using the Cochrane Risk of Bias 2.0 tool. Network meta-analysis was performed using Stata 18.0 and R 4.3.2, and treatment rankings were estimated based on surface under the cumulative ranking curve (SUCRA) probabilities.

Results:

A total of 81 randomized controlled trials involving 6,147 patients and 24 intervention strategies were included. Network meta-analysis demonstrated that: (1) For lower limb motor function (Fugl–Meyer Assessment, lower extremity), electromyography-triggered functional electrical stimulation combined with conventional functional electrical stimulation ranked highest (SUCRA = 89.0%), whereas conventional therapy ranked lowest (SUCRA = 4.3%). (2) For balance ability (Berg Balance Scale), multi-channel functional electrical stimulation showed the greatest efficacy (SUCRA = 85.6%), compared with conventional therapy (SUCRA = 4.2%). (3) For activities of daily living (Modified Barthel Index), closed-loop neuromuscular electrical stimulation was most effective (SUCRA = 71.9%), while conventional therapy ranked lowest (SUCRA = 3.0%). (4) For walking speed (10-Meter Walk Test), low-frequency electrical stimulation demonstrated superior efficacy (SUCRA = 66.2%) compared with neuromuscular electrical stimulation (SUCRA = 35.6%). (5) For functional ambulation (Functional Ambulation Category), transcranial direct current stimulation achieved the highest ranking (SUCRA = 99.7%).

Conclusion:

Different electrical stimulation modalities provide domain-specific benefits in post-stroke lower limb rehabilitation. Tailored selection of stimulation techniques may optimize functional recovery. Nevertheless, the overall evidence remains limited, and further large-scale, high-quality randomized trials are required to confirm these findings and elucidate underlying neuroregulatory mechanisms.

Systematic review registration:

PROSPERO, identifier CRD420251087696.

1 Introduction

Stroke is defined as a severe cerebrovascular disorder characterized by abrupt cessation of cerebral perfusion, resulting in neuronal injury or demise, and presenting with a clinical spectrum spanning mild functional deficits to profound disability (1). Globally, approximately 12.2 million new stroke cases, 101 million prevalent stroke cases, and 6.55 million stroke-related deaths were recorded (2). With the global prevalence of stroke continuing to rise, about 55–75% of stroke survivors experience motor dysfunction, among which lower limb dysfunction accounts for a significant proportion (3, 4). Stroke patients manifest heterogeneous degrees of lower extremity motor impairment, principally characterized by diminished muscular strength, spasticity (predominantly in periarticular musculature of the hip/knee/ankle complexes), and aberrant gait kinematics. Furthermore, the non-paretic limb demonstrates concomitant limitations including restricted knee joint range of motion, compromised muscular strength, and reduced movement velocity (5, 6). Such dysfunction substantially elevates fall susceptibility among stroke survivors, detrimentally affecting ambulatory capacity, activities of daily living (ADL), and quality of life while generating significant familial and societal caregiver burdens. Thus, lower extremity functional rehabilitation constitutes a critical therapeutic target for optimizing post-stroke prognosis.

The main treatment methods for lower limb dysfunction after stroke include conventional rehabilitation training and electrical stimulation. Conventional rehabilitation training (e.g., basic motor exercises, balance training, gait training) exhibits moderate efficacy in ameliorating limb function in stroke patients with lower limb dysfunction (7, 8) However, this regimen is constrained by protracted duration and protocol homogeneity, frequently inducing patient fatigue and consequently diminishing treatment adherence. Current clinical electrical stimulation strategies show a trend toward diversification, including Functional Electrical Stimulation (FES), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Direct Current Stimulation (tDCS), and Neuromuscular Electrical Stimulation (NMES). Electrical stimulation induces long-term synaptic plasticity alterations by directly modulating cerebral activity through electrical currents or magnetic fields applied to brain tissue (9). For example, FES activates motor neurons through emulation of physiological movement patterns, potentiating corticospinal tract excitability to enhance motor control (10, 11). The tDCS facilitates neuroplasticity by bidirectionally modulating cortical excitability—anodal stimulation augments excitability, while cathodal stimulation suppresses pathological hyperexcitability (12). Neuromuscular Electrical Stimulation optimizes muscle contraction force at 20-30 Hz frequencies to strengthen lower limb muscle power and motor function (13, 14). Nevertheless, current clinical research on post-stroke lower limb dysfunction primarily focuses on analyzing the efficacy of single-mode electrical stimulation combined with conventional rehabilitation, and there remains no unified conclusion regarding the comparative effects of different stimulation modalities.

As an emerging statistical methodology in evidence-based medicine, Network Meta-Analysis (NMA) concurrently synthesizes direct and indirect evidence, facilitating simultaneous evaluation of multiple interventions within a single analysis—including those lacking head-to-head comparisons in original studies—thereby generating clinically informative evidence for decision-making. Moreover, NMA enables hierarchical ranking of interventions according to their comparative efficacy and posterior probability of being the optimal treatment. This research implemented rigorous screening and synthesis of published clinical literature, utilizing NMA to comparatively evaluate the effects of diverse electrical stimulation modalities on lower limb motor function and ADL in stroke patients, with the objectives of furnishing robust evidence-based support for clinical practice, informing decision-making, and establishing an evidence-based reference framework.

2 Methods

This meta-analysis was conducted adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Network Meta-Analysis (PRISMA-NMA) statement. In Supplementary material 1, a list of PRISMA was provided. Furthermore, a study protocol was prospectively registered on the PROSPERO international prospective register of systematic reviews (Registration ID: CRD420251087696).

2.1 Search strategy

The search strategy was executed across seven bibliographic databases: CNKI, Wanfang Data, VIP, PubMed, Cochrane Library, Embase, and Web of Science. Search methodology incorporated a combination of controlled Medical Subject Headings (MeSH) vocabulary and unrestricted free-text terminology. The specific search strategies for each database are detailed in Supplementary material 2. Inclusion criteria restricted evidence sources to peer-reviewed publications exclusively in the Chinese or English languages.

2.2 Eligibility criteria

2.2.1 Inclusion criteria

① Study Type and Language: Randomized controlled trials (RCTs) on different electromagnetic stimulation therapies for post-stroke lower limb dysfunction, limited to Chinese and English publications. ② Patients with stroke (brain bleed or clot confirmed by CT/MRI scans) showing leg mobility issues. Must be adults (>18 years old)—no restrictions on gender or how long since stroke occurred. ③ Control group: Standard stroke care (meds/rehab) or placebo stimulation. Intervention group: Control treatment plus active stimulations (e.g., nerve/muscle stimulation, brain stimulation techniques) or direct comparisons between stimulation types. ④ Outcome Measures: Fugl-Meyer Assessment for Lower Extremity (FMA-L), Berg Balance Scale (BBS), Modified Barthel Index (MBI), 10-Meter Walk Test (10MWT), Functional Ambulation Category (FAC).

2.2.2 Exclusion criteria

①Non-randomized controlled trials. ② Publications with inaccessible full-text documents. ③ Literature published in languages other than Chinese or English. ④ Redundant publications (identical studies appearing in multiple sources). ⑥ Systematic reviews, animal experimentation, case reports, and conference proceedings.

2.3 Study selection

Following duplicate removal via EndNote X9 (2025 release), dual investigators independently conducted literature screening. Primary filtering utilized titles/keywords/abstracts, succeeded by full-text assessment for data extraction and cross-verification to ascertain eligible studies. A third reviewer audited the database, facilitating consensus resolution for any data extraction discrepancies. Extracted parameters comprised: primary author, publication year, sample size (intervention/control), mean age (intervention/control), therapeutic protocols (intervention/control), treatment duration, and outcome metrics.

2.4 Risk of bias and evidence quality assessment

The methodological risk of bias in included studies was appraised utilizing the Cochrane Risk of Bias Tool 2.0 (RoB 2.0). Per the Cochrane Handbook for Systematic Reviews of Interventions, dual reviewers independently conducted methodological quality assessments. Discordances in evaluations were reconciled via consensus deliberations or arbitration by an independent third reviewer. Assessments for individual trials prioritized five critical domains: ① Bias from randomization procedures. ② Bias from intervention deviations. ③ Bias from missing outcome data. ④ Bias in outcome measurement. ⑤ Bias in selective result reporting.

2.5 Statistical analysis

In this study, we conducted a Bayesian NMA using the gemtc package in R 4.3.2. Within the Bayesian framework, we specified 2,000 burn-in iterations followed by 50,000 sampling iterations. Convergence of the Markov chains was assessed through trace plots, posterior density plots, and the Brooks–Gelman–Rubin diagnostic, ensuring satisfactory mixing and model stability. Given the anticipated clinical diversity among the included trials—particularly regarding stimulation protocols, rehabilitation regimens, and participant characteristics—we prespecified a random-effects model for the NMA. To complement the network analysis and examine heterogeneity across direct comparisons, we additionally performed pairwise meta-analyses in Stata 18.0 where head-to-head data were available. For continuous outcomes, effect sizes were summarized using mean differences (MD) with corresponding 95% confidence intervals (95% CI). Statistical heterogeneity was quantified using the I2 statistic and its associated p value: a fixed-effect model was applied when I2 < 50% and p > 0.1, whereas a random-effects model was adopted when I2 ≥ 50% or p < 0.1. When appropriate, subgroup or sensitivity analyses were conducted to explore potential sources of heterogeneity. To evaluate the robustness of the findings, sensitivity analyses were performed for all key outcomes. For endpoints with at least 10 contributing studies, potential publication bias was examined using funnel plots and the Egger regression test (Stata 18.0). Symmetrical funnel plots together with an Egger test p > 0.05 were interpreted as indicating no significant publication bias.

3 Result

3.1 Research selection

The systematic search yielded 3,341 records distributed as follows: CNKI (n = 47), Wanfang Data (n = 515), VIP (n = 411), PubMed (n = 541), Web of Science (n = 1,065), Embase (n = 572), and Cochrane Library (n = 190). EndNote X9 (2025 release) identified and eliminated 1,346 duplicate records, resulting in 81 eligible studies for final inclusion. The detailed screening process is shown in Figure 1.

Figure 1

Flowchart detailing the identification of studies via databases and registers. Initially, 3,341 records were identified from multiple sources. After removing 1,346 duplicates, 1,995 records were screened, and 1,555 were excluded. Of the 440 reports sought for retrieval, 44 had no full article. In the eligibility assessment, 396 reports remained, with further exclusions for language, unmatched interventions, outcomes, and study designs. Ultimately, 81 studies were included in the review.

Flowchart of literature screening.

3.2 Research characteristic

A total of 8 RCTs involving 6,147 stroke patients with lower limb dysfunction were included. Across both cohorts, 24 distinct interventions were implemented, comprising 18 modalities of electrical stimulation therapy: tDCS, repetitive transcranial magnetic stimulation (rTMS), FES, low-frequency electrical stimulation (LFES), Intermediate-Frequency Electrical (LFES), deep muscle electrical stimulation (DFES), NMES, transcutaneous acupoint electrical stimulation (TAES), TENS, transcutaneous auricular vagus nerve stimulation (taVNS), controllable current neuromuscular electrical stimulation (CCNEMS), muscle-triggered electrical stimulation (EMG), FES cycling training (FES cycling), dual-channel FES (2-ch FES), quad-channel FES (4-ch FES), multi-channel FES (multi-ch FES), Fastigial Nucleus Stimulation (FNS), and multi-joint linked wearable FES (MJL-WFES). Among the 86 included studies, 62 evaluated FMA-L scores pre- and post-treatment. Furthermore, 38 studies utilized the BBS, 26 employed the MBI pre−/post-intervention, 11 implemented the 10MWT, and 9 applied the FAC. Basic characteristics of the included literature are presented in Table 1.

Table 1

Study ID Grouping method Age (C/I) Gender (male/female) Sample size(C/I) Course of disease Control group Intervention group Treatment Course Outcome
Liang X 2023 (63) A C: 66.25 ± 12.04
I: 66.11 ± 12.16
C: 26/17
I: 28/15
43/43 C: 3.45 ± 1.16 (m)
I: 3.33 ± 1.23
C: UC I: tDCS 3 weeks
Song L 2021 (64) A C: 61.17 ± 13.56
I: 61.92 ± 11.61
C: 16/4
I: 17/3
20/20 C: 17.69 ± 2.30(d)
I: 18.50 ± 1.84
C: UC I: FES-Cycling 4 weeks ①⑤
Wei J 2024 (65) A C: 68.41 ± 3.46
I: 68.95 ± 3.32
C: 52/47
I: 55/43
99/99 C: 34.73 ± 6.58(d)
I: 34.86 ± 6.86
C: UC I: FES 8 weeks ①②
Hu B 2022 (66) A C: 71.45 ± 2.14
I: 71.73 ± 2.48
C: 23/18
I: 24/17
41/41 C: 2.29 ± 0.44(m)
I: 2.17 ± 0.33
C: UC I: LFES 4 weeks
Sun X 2023 (67) B C: 65.17 ± 4.72
I: 64.98 ± 4.63
C: 37/41
I: 48/30
78/78 C: 1.69 ± 0.71(m)
I: 1.65 ± 0.78
C: UC I: LFES 8 weeks ①②③
Hong Y 2021 (68) A C: 49.82 ± 7.45
I: 50.23 ± 7.68
C: 28/19
I: 26/21
47/47 C: 18.67 ± 2.35(d)
I: 19.74 ± 3.06
C: UC I: LFES 4 weeks ①②
Zhang S 2023 (69) A C: 68.30 ± 3.35
I: 68.70 ± 3.40
C: 26/23
I: 25/24
49/49 C: 3.04 ± 0.60(d)
I: 3.19 ± 0.78
C: UC I: LFES 4 weeks ②⑤
Dong Y 2022 (70) A C: 64.85 ± 11.96
I: 63.67 ± 11.39
C: 45/15
I: 42/18
60/60 C: 41.84 ± 21.74(d)
I: 40.17 ± 22.65
C: UC I: LFES 12 weeks
Li L 2024 (71) A C: 62.96 ± 4.41
I: 62.85 ± 4.37
C: 28/22
I: 30/20
50/50 C: 35.47 ± 4.52(d)
I: 34.58 ± 4.96
C: UC I: LFES 12 weeks
Liang S 2022 (72) A C: 66.78 ± 6.53
I: 66.64 ± 6.29
C: 19/20
I: 22/18
39/40 C: 36.59 ± 10.25(d)
I: 36.67 ± 10.33
C: FES I: rTMS 3 weeks
Zong T 2012 (73) A C: 62.7 ± 5.28
I: 4.5 ± 6.54
C: 24/16
I: 23/17
40/40 C: 23.6 ± 7.08(d)
I: 24.5 ± 5.88
C: UC I: IFES 4 weeks
Wang L 2023 (74) A C: 59.20 ± 7.94
I: 59.75 ± 7.58
C: 8/12
I: 9/11
20/20 C: 61.40 ± 11.21(d)
I: 61.05 ± 11.45
C: UC I: multi-ch FES 4 weeks
  • ①④

Shi Z (75) 2023 A C: 67.39 ± 2.20
I: 67.43 ± 2.26
C: 26/23
I: 25/24
49/49 C: 26.20 ± 2.58(d)
I: 26.24 ± 2.61
C: UC I: multi-ch FES 4 weeks
  • ①②⑤

Liu D 2020 (15) C C: 53.97 ± 3.52
I: 53.72 ± 3.47
C: 9/4
I: 7/6
13/12 C: 62.27 ± 3.56(d)
I: 63.43 ± 4.72
C: UC I: FES
3 weeks ①⑤
Wang Y 2018 (76) B C: 64.20 ± 7.22
I: 62.50 ± 5.19
C: 6/4
I: 7/3
10/10 C: 16.56 ± 1.67
I: 16.10 ± 1.79
C: UC I: FES-Cycling 4 weeks ①③
Ren H 2018 (77) A C: 68.53 ± 10.37
I1: 70.65 ± 9.98
I2: 67.32 ± 8.79
I3: 69.77 ± 7.86
C: 13/7
I1: 11/9
I2: 13/7
I3: 10/10
20/20/20/20 C: 5.31 ± 1.73(m)
I1: 4.52 ± 2.21
I2: 5.16 ± 1.99
I3: 4.78 ± 2.07
C: UC I1: EMG-FES
I2: FES
I3: EMG-FES + FES
8 weeks ①④
Xu C 2024 (78) B C: 43.32 ± 4.64
I: 44.43 ± 4.58
C: 26/26
I: 28/23
52/52 C: 1.68 ± 0.23(M)
I: 1.61 ± 0.25
C: UC I: FES 6 weeks
Chen D 2020 (79) B C: 65.510.2
I: 64.9 ± 10.5
C: 16/14
I: 18/12
20/20 C: 21.08 ± 6.18(d)
I: 21.39 ± 6.18
C: UC I: FES 2 weeks
  • ①②④⑤

Ding B 2022 (80) A C: 68.2 ± 4.6
I: 69.1 ± 4.7
C: 20/18
I: 22/16
38/38 C: 39.3 ± 5.89d(d)
I: 40.2 ± 5.7
C: UC I: FES 2 weeks ①②
Ma Q 2016 (81) A C: 54.59 ± 9.47
I: 53.57 ± 8.04
C: 11/12
I: 10/12
22/23 C: 85.43 ± 23.89(d)
I: 84.27 ± 22.42
C: UC I: FES 8 weeks ①④
Liu Y 2021 (17) D C: 44.00 ± 9.58
I: 45.90 ± 8.93
C: 11/9
I: 10/10
20/20 C: 3.40 ± 1.02(m)
I: 3.60 ± 1.25
C: UC
I: C + FES
I: FES 4 weeks
Sun B 2020 (82) A I: 56.02 ± 8.22
C: 55.94 ± 8.38
I: 24/17
C: 22/19
41/41 I: 2.26 ± 0.27(m)
C: 2.21 ± 0.39
C: UC I: FES NR
  • ①②

Zheng L 2014 (83) B C: 53.6 ± 9.7
I: 57.6 ± 8.5
C: 10/6
I: 12/4
16/16 C: 25.5 ± 5.0(d)
I: 29.5 ± 7.0
C: UC I: FES 4 weeks ①②
Xu Y 2023 (84) A C: 61.00 ± 5.03
I: 60.16 ± 6.52
C: 24/18
I: 22/20
42/42 C: 25.47 ± 3.00(d)
I: 26.21 ± 3.49
C: 2-ch FES I: multi-ch FES 3 weeks
  • ①②③

Ma Y 2011 (85) B 53.80 ± 13.04 39/21 30/30 103.56 ± 22.48(d) C: UC I: TENS 4 weeks
Cao L 2022 (86) A C: 60.24 ± 6.56
I: 59.87 ± 6.61
C: 30/26
I: 32/24
56/56 C: 3.21 ± 0.84(m)
I: 3.26 ± 0.80
C: UC I: TENS 4 weeks
  • ①③

Peng Y 2015 (18) E C: 68.8 ± 10.6
I: 65.4 ± 12.8
C:11/9
I:12/9
20/21 C: 1.85 ± 1.15(m)
I: 2.05 ± 0.85
C: UC I: TEAS 3 weeks ①②
Chen C 2016 (87) B C: 60.59 ± 10.75
I: 59.38 ± 9.59
C: 13/4
I: 14/2
17/16 C: 67.76 ± 30.87(d)
I: 65.44 ± 29.25
C: UC I: TEAS 4 weeks
  • ①③

Wang Q 2023 (88) A C: 58.46 ± 8.95
I: 57.60 ± 9.41
C: 24/14
I: 26/12
38/38 C: 42.74 ± 17.28(d)
I: 41.63 ± 18.03
C: UC I: TEAS 4 weeks ①②
Wang Z 2024 (31) A C: 66.48 ± 10.91
I: 65.87 ± 10.79
C: 55/27
I: 59/24
82/83 C: 47.08 ± 7.36(d)
I: 46.21 ± 7.22
C: UC I: TEAS+tDCS 4 weeks
  • ①④⑤

Gong X 2024 (89) A C: 56.53 ± 11.02
I: 60.42 ± 13.21
C: 10/5
I: 11/4
15/15 C: 2.12 ± 2.78(m)
I: 2.34 ± 2.2
C: UC I: tDCS 2 weeks
Zhang Q 2025 (90) A C: 63.23 ± 6.70
I: 61.22 ± 8.65
C: 23/12
I: 28/8
35/36 C: 3.91 ± 1.01
I: 4.00 ± 0.76
C: UC I: DEMS
4 weeks
Qiu Z 2022 (91) A C: 61.45 ± 3.35
I: 61.33 ± 3.27
C: 15/26
I: 14/27
41/41 C: 20.45 ± 3.15(d)
I: 20.36 ± 3.02
C: UC I: NEMS 12 weeks
  • ②③

Yang M 2023 (92) A C: 61.34 ± 3.55
I: 61.72 ± 2.15
C: 39/36
I: 38/37
75/75 C: 4.51 ± 0.32(m)
I: 4.59 ± 0.24
C: UC I: NEMS 4 weeks
  • ①②

Wen X 2021 (93) B C: 66.1 ± 3.7
I: 65.3 ± 3.2
C: 26/18
I: 24/20
44/44 C: 4.19 ± 0.40(w)
I: 4.25 ± 0.36
C: UC I: NEMS 4 weeks
Yan X 2023 (94) B C: 63.21 ± 3.11
I: 63.23 ± 3.14
C: 18/22
I: 21/19
40/40 C: 4.57 ± 1.03(w)
I: 4.59 ± 1.01
C: UC I: NEMS 10 weeks
Zhang G 2023 (95) A C: 60.37 ± 5.47
I: 60.33 ± 5.54
C: 24/26
I: 25/25
50/50 C: 2.03 ± 0.44(m)
I: 2.13 ± 0.38
C: UC I: IFES 8 weeks
Wang L 2024 (25) F I1: 64.93 ± 10.54
I2: 61.65 ± 9.33
C: 61.00 ± 9.67
I1: 11/16
I2: 8/17\u00B0C: 6/14
27/25/20 I1: 12.37 ± 6.15 (d)
I2: 16.42 ± 4.71
C: 15.86 ± 6.59
C: UC I1: rTMS
I2: Placebo
6 weeks
  • ①②③

Zhang X. H. 2021 (96) A C: 57.31 ± 10.53
I: 55.76 ± 11.78
C: 16/17
I: 13/20
33/33 C: 42.45 ± 4.75(d)
I: 43.55 ± 5.66
C: UC I: FES-Cycling 8 weeks ①③
Bilek, F 2020 (28) B C: 62.6 ± 2.2
I: 51.3 ± 3.7
C: 16/14
I: 13/17
30/30 3 months C: UC I: NEMS 6 weeks
Shuji, M 2023 (22) G C: 64.3 ± 11.8
I: 63.5 ± 10.5
C: 70/22
I: 68/24
92/92 C: 63.7 ± 30.4(d)
I: 59.5 ± 32.6
C: UC I: FES 8 weeks ①④
Zhang X 2021 (32) B C: 58.18 ± 11.70
I: 56.11 ± 12.0
C: 38/23
I: 43/18
61/61 C: 43.45 ± 5.66(d)
I: 42.45 ± 4.75
C: FES I: tDCS 8 weeks
  • ①③⑤

Ying Shen 2022 (24) F C: 66.09 ± 6.38
I: 62.86 ± 12.96
C: 15/6
I: 18/3
21/21 C: 73.45 ± 33.15
I: 84.00 ± 39.60(d)
C: NEMS I: CCNEMS 3 weeks ①③
Tan Z 2014 (30) A C: 67.0 ± 9.0
I1: 63.4 ± 10.6
I2: 64.6 ± 8.3
C: 8/9
I1: 8/8
I2: 8/6
17/16/15 C: 41.5 ± 20.4(d)
I1: 41.3 ± 29.4
I2: 41.6 ± 22.1
C: UC I1: 4-ch FES
I2: 2-ch FES
3 weeks
  • ①②③⑤

Jung K. S 2020 (16) C C: 52.7 ± 11.5
I: 53.1 ± 7.9
C: 12/8
I: 14/6
20/20 C: 7.0 ± 2.6(m)
I: 6.8 ± 2.5
C: Placebo I: TENS 6 weeks
Hsu S. P 2023 (97) B C: 59.2 ± 11.8
I: 59.1 ± 11.4
C: 6/8
I: 9/4
13/14 C: 21.1 ± 5.3(d)
I: 20.7 ± 3.5
C: UC I: tDCS 2 weeks
Litong Wang 2024 (98) A C: 61.94 ± 3.28
I1: 61.54 ± 5.78
I2: 60.82 ± 6.19
I3: 63.13 ± 5.75
C: 17/23
I1: 22/21
I2: 21/23
I3: 18/24
40/43/44/42 C: 18.89 ± 5.17(d)
I1: 18.98 ± 4.56
I2: 619.24 ± 5.83
I3: 20.05 ± 4.28
C: UC I1: taVNS+tDCS
I2: taVNS
I3: tDCS
4 weeks
  • ①②③

Dujovic S. D. 2017 (99) B 65 C: 7/1
I: 3/5
8/8 6 (m) C: UC I: FES 4 weeks
  • ①②③

Zheng X 2018 (100) B C: 59 ± 9
I1: 59 ± 11
I2: 60 ± 9
C: 9/6
I1: 9/9
I2: 9/6
15/18/15 C: 20 ± 12(d)
I1: 20 ± 11
I2: 21 ± 13
C: UC I1: 4-ch FES
I2: 2-ch FES
3 weeks
  • ①②③

Yang T 2018 (101) F C: 60.60 ± 8.33
I: 63.07 ± 4.46
C: /6
I: /7
15/15 C: 7.40 ± 14.51(d)
I: 9.53 ± 15.90
C: NEMS I: FES 4 weeks ①④
Xu J 2015 (102) B C: 63.1 ± 10.1
I: 65.6 ± 12.7
C: 4/16
I: 7/13
40/40 2.5-8(d) C: UC I: NEMS 2 weeks
Li J 2023 (23) I C: 65.19 ± 7.15
I: 65.26 ± 7.04
C: 25/18
I: 22/20
43/42 C: 5.28 ± 0.67(d)
I: 5.36 ± 0.67
C: UC I: LFES 12 weeks ①②
Chen J 2006 (103) B C: 61.5 ± 3.5
I: 62.0 ± 3.2
C: 17/8
I: 16/9
25/25 1 ~ 4 days C: UC I: LFES 20 days
Yan G 2009 (29) B C: 54.8 ± 6.3
I: 55.2 ± 6.8
C: 17/13
I: 19/12
30/31 C: 4.7 ± 0.5(d)
I: 4.6 ± 0.5
C: UC I: LFES 2 weeks ①③
Zhou J 2003 (104) B C: 62.38 ± 11.5
I: 59.35 ± 8.75
C: 22/18
I: 21/19
40/40 ≤72 h C: UC I: FNS 10 days
Liu J 2024 (27) S C: 50.73 ± 11.25
I: 49.13 ± 10.79
C: 9/6
I: 11/14
15/15 C: 6.60 ± 3.42(m)
I: 6.67 ± 3.64
C: UC I: MJL-WFES 4 weeks ①③
Xu D 2019 (105) B C: 57.49 ± 9.9
I: 54.09 ± 14.73
C: 20/15
I: 25/10
35/35 C: 2.91 ± 2.32(m)
I: 2.49 ± 1.67
C: UC I: multi-ch FES 4 weeks
Jin G 2017 (26) H C: 59.4 ± 6.2
I: 59.6 ± 6.1
C: 18/16
I: 20/14
34/34 <1 week C: 2-ch FES I: multi-ch FES 3 weeks ①②
Chen D 2013 (106) B C: 56.0 ± 8.8
I: 50.5 ± 10.7
C: 6/2
I: 7/3
8/10 C: 15.9 ± 6.0(d)
I: 17.0 ± 8.2
C: UC
I: FES
I: FES 3 weeks ①②
Liu J 2021 (107) A C: 55.10 ± 14.01
I: 58.43 ± 9.52
C: 8/7
I: 9/6
15/15 C: 6.47 ± 1.83(m)
I: 6.73 ± 1.81
C: UC I: multi-ch FES 5 weeks ①③
Li G 2019 (108) A C: 58.40 ± 7.02
I: 58.53 ± 7.13
C: 16/14
I: 17/13
30/30 C:12.67 ± 7.56(d)
I:13.07 ± 8.13
C: UC I: FES 2 weeks ①②
Zhan S 2021 (109) A C: 63.6 ± 5.3
I: 65.1 ± 4.8
C: 43/30
I: 47/26
73/73 C: 0.6 ± 0.3(m)
I: 0.7 ± 0.2
C: UC I: FES 3 weeks
You G 2007 (20) E C: 64.1 ± 9.7
I: 60.8 ± 10.8
C: 10/8
I: 11/8
18/19 C: 22.7 ± 16.6(d)
I: 25.9 ± 21.3
C: UC I: 2-ch FES 3 weeks ①②
You G 2013 (19) E C: 64.2 ± 8.8
I1: 62.7 ± 10.9
I2: 61.6 ± 9.7
C: 15/7
I1: 13/10
I2: 14/9
22/23/23 C: 25.2 ± 19.4(d)
I1: 24.6 ± 20.2
I2: 23.7 ± 16.9
C: UC I1: 2-ch FES
I2: Placebo
3 weeks ①②
Cai C 2021 (110) B C: 56.43 ± 13.05
I: 57.20 ± 13.48
C: 74/26
I: 77/23
100/100 NR C: UC I: FES 8 weeks
  • ①②④

Yang L 2017 (111) A C: 58.6 ± 13.8
I: 59.1 ± 13.3
C: 18/12
I: 18/12
30/30 C: 17.4 ± 5.8(d)
I: 17.7 ± 6.3
C: UC I: EMG-FES 8 weeks ①②
Zhao J 2023 (112) A C: 54.98 ± 4.32
I: 54.37 ± 4.54
C: 12/8
I: 10/10
20/20 C: 13.65 ± 2.31(d)
I: 13.87 ± 2.42
C: UC I: tDCS 4 weeks
Guo T 2015 (113) B C: 59.59 ± 10.02
I: 58.33 ± 9.26
C: 20/20
I: 19/11
30/30 NR C: UC I: tDCS 4 weeks
Geng J 2021 (114) A C: 57.37 ± 13.16
I: 60.50 ± 13.21
C: 19/12
I: 18/13
31/31 C: 12.11 ± 2.08(d)
I: 11.84 ± 1.8
C: FES-cycling I: tDCS 4 weeks ①③
Chen H 2021 (21) E C: 50.1 ± 11.5
I1: 44.4 ± 12.8
I2: 48.4 ± 13.2
C: 14/4
I1: 14/5
I2: 13/6
18/19/19 3-6(m) C: tDCS I1: FES
I2: tDCS+FES
12 days
  • ①②③

Cheng A 2005 (115) A 58 ± 5 38/22 30/30 NR C: UC I: TENS 4 weeks
Zhang H 2013 (116) B C: 65.23 ± 9.21
I: 64.89 ± 7.73
C: 26/24
I: 25/25
50/50 C:26.35 ± 15.23(d)
I:25.62 ± 12.67
C: UC I: TEAS 2 weeks
Chen X 2025 (117) A C: 63.33 ± 1.36
I: 63.36 ± 1.39
C: 21/13
I: 21/14
34/35 NR C: UC
1次/d
I: LFES 8 weeks
Wang P 2023 (118) A C: 45.98 ± 6.25
I: 46.86 ± 6.87
C: 14/15
I: 16/13
29/29 C: 12.95 ± 3.52(d)
I: 13.98 ± 3.67
C: UC I: DEMS 8 weeks
Yang Y 2015 (119) A 65.8 ± 9.2 126/34 80/80 NR C: UC I: NEMS 12 weeks
Yang Y 2016 (120) A C: 63.62 ± 12.81
I: 62.73 ± 12.47
C: 22/18
I: 22/18
40/40 NR C: UC I: NEMS 8 weeks
Li X 2021 (121) B C: 56.26 ± 9.36
I: 59.21 ± 9.25
C: 32/28
I: 34/26
60/60 <3 months C: UC I: NMES 4 weeks ①②
Chen Y 2021 (122) B C: 68.31 ± 7.80
I1: 63.37 ± 10.99
I2: 62.35 ± 10.80
C: 10/6
I1: 8/8
I2: 6/11
16/16/16 C: 6.58 ± 2.16(m)
I1: 6.66 ± 2.24
I2: 5.81 ± 2.09
C: Placeo I1: 2-ch FES
I2: 4-ch FES
2 weeks ①②
Deng W 2023 (123) A C: 60.56 ± 1.15
I: 60.62 ± 1.21
C: 25/15
I: 23/17
40/40 NR C: CRT I: IFES 4 weeks
Sun L 2014 (124) A C: 63.95
I: 65.95
C: 6/14
I: 14/6
20/20 6.8 weeks C: UC I: EMG-FES 8 weeks
Yu J 2010 (125) B C: 52.0 ± 6.8
I1: 51.4 ± 7.2
I2: 51.8 ± 6.2
C: 11/9
I1: 8/12
I2: 11/9
20/20/20 C: 21.6 ± 0.93(d)
I1: 22.8 ± 8.8
I2: 20.2 ± 10.1
C: UC I1: FES
I2: EMG-FES
8 weeks

Characteristics of included studies.

A: Random number table; B: Random; C: Treatment modality; D: Order of admission; E: Minimize; F: Sealed envelope; G: eClinical Base; H: Lottery method; I: Mendelian Randomization; S: SPSS 25.0; UC: Usual Care. The meaning of the number represented in the Outcome details: ①FMA-L score, ② BBS score, ③ MBI score, ④ 10MWT, ⑤AC score.

3.3 Risk of bias of included studies

Regarding the randomization process, 54 studies (64.7%) clearly reported the methods used to generate random allocation sequences. Among them, 41 trials employed random number tables, two allocated participants (15, 16) utilized treatment-based allocation; 1 study (17) used admission chronology; 4 studies (18–21) mplemented Minimization methodology; 1 study (22) applied eClinical Base platform; 1 study (23) adopted Mendelian randomization; 2 studies (24, 25) applied sealed envelope concealment; 1 study (26) utilized lottery allocation; and 1 study (27) employed SPSS 25.0 software. The remaining 27 studies (35.3%) mentioned the use of “randomization” without specifying the method. To evaluate baseline comparability after randomization, we systematically reviewed the baseline data for age, sex distribution, and primary outcome measures as presented in Table 1. Most studies demonstrated balanced baseline characteristics between intervention groups (p > 0.05) and were therefore rated as having a low risk of bias. A small number of trials—for example, the study by Bilek (28), where age distributions differed significantly between groups—were judged to have a high risk of bias. With respect to outcome completeness, three studies exhibited incomplete data due to participant attrition, indicating a potential risk of attrition bias. No evidence of selective reporting or other identifiable sources of bias was detected. Taken together, the methodological quality of the included studies was generally modest. The detailed distribution of risk-of-bias assessments is presented in Figure 2 and Table 2.

Figure 2

Bar chart showing bias assessment in percentages across six categories: overall bias, selection of the reported result, measurement of the outcome, missing outcome data, deviations from intended interventions, and randomization process. Green indicates low risk, yellow indicates some concerns, and red indicates high risk. Most categories show significant high risk, especially overall bias and measurement of outcome. Missing outcome data is mostly low risk, while the randomization process has some concerns.

Risk of bias graph.

Table 2

Study ID Randomization process Deviations from intended interventions Missing outcome data Measurement of the outcome Selection of the reported result Overall
Liang X 2023 (63) Some concerns High risk Low risk High risk Some Concerns High risk
Song L 2021 (64) Some concerns High risk Low risk High risk Some Concerns High risk
Wei J 2024 (65) Some concerns High risk Low risk High risk Some Concerns High risk
Hu B 2022 (66) Some concerns High risk Low risk High risk Some Concerns High risk
Sun X 2023 (67) Some concerns High risk Low risk High risk Some Concerns High risk
Hong Y 2021 (68) Some concerns High risk Low risk High risk Some Concerns High risk
Zhang S 2023 (69) Some concerns High risk Low risk High risk Some Concerns High risk
Dong Y 2022 (70) Some concerns High risk Low risk High risk Some Concerns High risk
Li L 2024 (71) Some concerns High risk Low risk High risk Some Concerns High risk
Liang S 2022 (72) Some concerns High risk Low risk High risk Some Concerns High risk
Zong T 2012 (73) Some concerns High risk Low risk High risk Some Concerns High risk
Wang L 2023 (74) Some concerns High risk Low risk High risk Some Concerns High risk
Shi Z 2023 (75) Some concerns High risk Low risk High risk Some Concerns High risk
Liu D 2020 (15) Some concerns High risk Low risk High risk Some Concerns High risk
Wang Y 2018 (76) Some concerns High risk Low risk High risk Some Concerns High risk
Ren H 2018 (77) Some concerns High risk Low risk High risk Some Concerns High risk
Xu C 2024 (78) Some concerns High risk Low risk High risk Some Concerns High risk
Chen D 2020 (79) Some concerns High risk Low risk High risk Some Concerns High risk
Ding B 2022 (80) Some concerns High risk Low risk High risk Some Concerns High risk
Ma Q 2016 (81) Some concerns High risk Low risk High risk Some Concerns High risk
Liu Y 2021 (17) Some concerns High risk Low risk High risk Some Concerns High risk
Sun B 2020 (82) Some concerns High risk Low risk High risk Some Concerns High risk
Zheng L 2014 (83) Some concerns High risk Low risk High risk Some Concerns High risk
Xu Y 2023 (84) Some concerns High risk Low risk High risk Some Concerns High risk
Ma Y 2011 (85) Some concerns High risk Low risk High risk Some Concerns High risk
Cao L 2022 (86) Some concerns High risk Low risk High risk Some Concerns High risk
Peng Y 2015 (18) Some concerns High risk Low risk High risk Some Concerns High risk
Chen C 2016 (87) Some concerns High risk Low risk High risk Some Concerns High risk
Wang Q 2023 (88) Some concerns High risk Low risk High risk Some Concerns High risk
Wang Z 2024 (31) Some concerns High risk Low risk High risk Some Concerns High risk
Gong X 2024 (89) Some concerns High risk Low risk High risk Some Concerns High risk
Zhang Q 2025 (90) Some concerns High risk Low risk High risk Some Concerns High risk
Qiu Z 2022 (91) Some concerns High risk Low risk High risk Some Concerns High risk
Yang M 2023 (92) Some concerns High risk Low risk High risk Some Concerns High risk
Wen X 2021 (93) Some concerns High risk Low risk High risk Some Concerns High risk
Yan X 2023 (94) Some concerns High risk Low risk High risk Some Concerns High risk
Zhang G 2023 (95) Some concerns Some concerns Low risk Low risk Some Concerns Some Concerns
Wang L 2024 (25) Some concerns High risk Low risk High risk Some Concerns High risk
Zhang X. H 2021 (96) Some concerns Some concerns Low risk Low risk Some Concerns Some Concerns
Bilek, F 2020 (28) High risk Some concerns Low risk Low risk Some Concerns High risk
Shuji, M 2023 (22) Some concerns High risk Low risk High risk Some Concerns High risk
Zhang X 2021 (32) Some concerns Some concerns Low risk Low risk Some Concerns Some Concerns
Ying Shen 2022 (24) Some concerns High risk Low risk High risk Some Concerns High risk
Tan Z 2014 (30) Some concerns Some concerns Low risk Low risk Some Concerns Some Concerns
Jung K. S 2020 (16) Some concerns Some concerns Low risk Low risk Some Concerns Some Concerns
Hsu S. P 2023 (97) Some concerns Some concerns Low risk Low risk Some Concerns Some Concerns
Litong W 2024 (98) Some concerns High risk Low risk High risk Some Concerns High risk
Dujovic 2017 (99) Some concerns High risk High risk High risk Some Concerns High risk
Zheng X 2018 (100) Some concerns Some concerns Low risk Low risk Some Concerns Some Concerns
Yang T 2018 (101) Some concerns High risk Low risk High risk Some Concerns High risk
Xu J 2015 (102) Some concerns High risk Low risk High risk Some Concerns High risk
Li J 2023 (23) Some concerns High risk Low risk High risk Some Concerns High risk
Chen J 2006 (103) Some concerns High risk Low risk High risk Some Concerns High risk
Yan G 2009 (29) Some concerns Low risk Low risk High risk Some Concerns High risk
Zhou J 2003 (104) Some concerns High risk High risk High risk Some Concerns High risk
Liu J 2024 (27) Some concerns High risk Low risk High risk Some Concerns High risk
Xu D 2019 (105) Some concerns High risk Low risk High risk Some Concerns High risk
Jin G 2017 (26) Some concerns High risk Low risk High risk Some Concerns High risk
Chen D 2013 (106) Some concerns High risk High risk High risk Some Concerns High risk
Liu J 2021 (107) Some concerns High risk Low risk High risk Some Concerns High risk
Li G 2019 (108) Some concerns High risk Low risk High risk Some Concerns High risk
Zhan S 2021 (109) Some concerns High risk Low risk High risk Some Concerns High risk
You G 2007 (20) Some concerns High risk Low risk High risk Some Concerns High risk
You G 2013 (19) Some concerns High risk Low risk High risk Some Concerns High risk
Cai C 2021 (110) Some concerns High risk Low risk High risk Some Concerns High risk
Yang L 2017 (111) Some concerns High risk Low risk High risk Some Concerns High risk
Zhao J 2023 (112) Some concerns High risk Low risk High risk Some Concerns High risk
Guo T 2015 (113) Some concerns High risk Low risk High risk Some Concerns High risk
Geng J 2021 (114) Some concerns High risk Low risk High risk Some Concerns High risk
Chen H 2021 (21) Some concerns High risk Low risk High risk Some Concerns High risk
Cheng A 2005 (115) Some concerns High risk Low risk High risk Some Concerns High risk
Zhang H 2013 (116) Some concerns High risk Low risk High risk Some Concerns High risk
Chen X 2025 (117) Some concerns High risk Low risk High risk Some Concerns High risk
Wang P 2023 (118) Some concerns High risk Low risk High risk Some Concerns High risk
Yang Y 2015 (119) Some concerns High risk Low risk High risk Some Concerns High risk
Yang Y 2016 (120) Some concerns High risk Low risk High risk Some Concerns High risk
Li X 2021 (121) Some concerns High risk Low risk High risk Some Concerns High risk
Chen Y 2021 (122) Some concerns High risk Low risk High risk Some Concerns High risk
Deng W 2023 (123) Some concerns High risk Low risk High risk Some Concerns High risk
Sun L 2014 (124) Some concerns High risk Low risk High risk Some Concerns High risk
Yu J 2010 (125) Some concerns High risk Low risk High risk Some Concerns High risk

Risk of bias (RoB 2.0) summary for included trials.

3.4 Pairwise meta-analysis

We performed pairwise meta-analyses for all interventions, yielding 5 outcomes. Forest plots and heterogeneity analyses for the pairwise meta-analysis results are presented in Supplementary material 3. Heterogeneity analysis revealed high heterogeneity across most electrical stimulation protocols, except for the BBS score outcome (I2 = 0%). Given the potential high heterogeneity arising from varying treatment durations, we conducted subgroup analyses based on treatment duration. Detailed results are shown in Supplementary material 3. After subgroup analysis, significant heterogeneity persisted in the FMA-L score outcome for both the ≤6-week and >6-week disease duration subgroups (original I2 = 94.09 and 89.59%, respectively). Heterogeneity predominantly originated from studies exhibiting extreme effect sizes (e.g., Yanguoping (29)), with the underlying mechanism being increased efficacy dispersion attributable to inter-study variations in electrical stimulation parameters (intensity/frequency). Sensitivity analysis following the exclusion of these effect size outliers significantly attenuated heterogeneity, thereby validating the therapeutic advantage of electrical stimulation for enhancing lower limb motor function in stroke patients and furnishing high-grade evidence for individualized rehabilitation protocols. In the MBI analysis, significant baseline heterogeneity was observed in both ≤6-week and >6-week subgroups (I2 = 94.58% each). Heterogeneity was mainly driven by extreme effect sizes (e.g., 34.06 points in Yanguoping (29) vs. -2.10 points in Zhimei Tan (30)), attributable to efficacy dispersion caused by parameter variations. Post-exclusion sensitivity analysis substantially reduced heterogeneity (overall I2 decreased from 65.62 to 18.18%), confirming electrical stimulation’s benefits for improving activities of daily living. Analysis of the 10MWT revealed substantial heterogeneity in both the ≤4-week and >4-week disease duration subgroups. This was principally caused by distortion of the pooled effect size due to disproportionate weighting from an ultra-large sample study (Wangzhida (31), constituting 45% of subgroup data). Exclusion of this study yielded significant heterogeneity reduction. This revealed electrical stimulation’s significantly superior efficacy for improving walking function in acute versus chronic phases. For the FAC analysis, high heterogeneity existed in the ≤4-week subgroup (I2 = 84.80%), primarily driven by the extreme effect size in Xiaohua Zhang (32) (1.41 [1.16, 1.66]), where tDCS efficacy significantly surpassed other interventions (validated by Surface Under the Cumulative Ranking Analysis (SUCRA)). The >4-week subgroup showed minimal heterogeneity (I2 = 0.00%), indicating stable efficacy in chronic stages. After excluding high-heterogeneity studies, short-term treatment group heterogeneity decreased significantly (I2 = 0.00%), confirming tDCS’s pivotal role in improving acute-phase walking function.

3.5 Network meta-analysis

The network structure of all outcomes is shown in Figure 3. We tested the convergence of all outcome models. The trace and density plots in Supplementary material 4 reveal extensive chain overlap, precluding visual discrimination of individual chain iterations. All curves approximate a normal distribution with stable bandwidth values. Brooks-Gelman-Rubin diagnostics in Supplementary material 5 demonstrate convergence: reduction factor medians and 97.5% quantiles approach 1, with all PSRF values at unity. Thus, all outcome models demonstrate excellent convergence. SUCRA values were computed for five outcomes under various interventions, with treatment rankings derived from the area under the cumulative probability curve (Figure 4).

Figure 3

Five network diagrams labeled A to E depict connections among various treatments, marked by nodes and interconnecting lines of varying thickness, indicating relationship strength. The central node labeled "UC" connects to others like "FES," "tDCS," and "taVNS." Different diagrams focus on varied connections and node sizes, with nodes like "EMG-FES," "rTMS," and "NEMS" varying in position and connectivity across diagrams. Each configuration visualizes a distinct emphasis on treatment interrelations.

Evidence relationship diagram of different interventions in the included studies. (A) FMA-L score; (B) BBS score; (C) MBI score; (D) 10MWT; (E) FAC score.

Figure 4

Five cumulative ranking probability plots labeled A to E, each displaying various treatments with different dashed lines and colors. The x-axis represents rank, while the y-axis is the probability percentage. Each plot has a unique set of treatments, with shared and varied colors across all five plots. The purpose is to compare and illustrate the effectiveness of different treatments by ranking probabilities within each plot.

Cumulative probability plot of the therapeutic effects of different interventions in the included studies. (A) FMA-L score; (B) BBS score; (C) MBI score; (D) 10MWT; (E) FAC score.

3.5.1 FMA-L

A total of 62 studies involving 4,520 subjects reported FMA-L outcomes. Interventions included: 4 FES-Cycling, 18 FES, 5 LFES, 2 rTMS, 5 multi-ch FES, 4 EMG-FES, 1 EMG-FES + FES, 4 4-ch FES, 7 2-ch FES, 3 TENS, 4 TEAS, 1 TEAS+tDCS, 1 DEMS, 7 NEMS, 5 tDCS, 1 CCNEMS, 1 MLJ-WFES, 1 taVNS+tDCS, 1 taVNS, 1 FNS, and 1 IFES. The EMG-FES + FES intervention demonstrated maximal efficacy in augmenting the area under the curve for BBS scores (SUCRA: 89.0%), contrasting with minimal efficacy observed for usual care (SUCRA: 4.3%). The SUCRA-derived hierarchy of interventions for FMA-L score enhancement was: EMG-FES + FES (89.0%) > rTMS (75.9%) > IFES (70.3%) > taVNS+tDCS (66.2%) > LFES (64.4%) > TENS (63.0%) > CCNEMS (61.7%) > TEAS+tDCS (60.8%) > EMG-FES (60.5%) > DEMS (60.1%) > 4-ch FES (59.7%) > multi-ch FES (58.4%) > FES + tDCS (56.6%) > FES (49.7%) > tDCS (47.8%) > taVNS (42.8%) > FNS (39.5%) > MLJ-WFES (37.6%) > TEAS (34.9%) > FES-Cycling (34.1%) > NEMS (32.0%) > 2-ch FES (24.0%) > Placebo (6.7%) > UC (4.3%).

3.5.2 BBS

A total of 38 studies involving 3,208 subjects reported 10MWT outcomes. Interventions included: 7 tDCS, 10 FES, 7 LFES, 2 multi-ch FES, 4 4-ch FES, 7 2-ch FES, 2 TEAS, 3 NEMS, 1 IFES, 1 rTMS, 1 EMG-FES, 1 taVNS+tDCS, 1 taVNS, 1 DEMS, and 1 FES + tDCS. Multi-channel functional electrical stimulation (multi-ch FES) exhibited maximal efficacy in enhancing the area under the curve for Berg Balance Scale scores (SUCRA: 85.6%), contrasting with minimal therapeutic effect from usual care (SUCRA: 4.2%). The therapeutic hierarchy for Berg Balance Scale enhancement, derived from SUCRA metrics, was: multi-ch FES (85.6%) > rTMS (76.0%) > taVNS+tDCS (75.2%) > DEMS (73.9%) > FES + tDCS (59.2%) > EMG-FES (58.4%) > LFES (57.0%) > FES (55.7%) > 4-ch FES (53.9%) > IFES (48.6%) > taVNS (45.0%) > TEAS (44.0%) > tDCS (38.7%) > NEMS (34.4%) > 2-ch FES (28.5%) > Placebo (11.6%) > UC (4.2%).

3.5.3 MBI

A total of 26 studies involving 1,886 subjects reported 10MWT outcomes. Interventions included: 3 LFES, 2 multi-ch FES, 3 FES-Cycling, 3 2-ch FES, 3 4-ch FES, 3 TENS (2 + 1 studies), 2 TEAS, 4 NEMS, 3 FES, 1 rTMS, 5 tDCS, 1 CCNEMS, 1 taVNS+tDCS, 1 taVNS, and 1 MJL-WFES. CCNEMS exhibited maximal efficacy in augmenting the area under the curve for Modified Barthel Index scores (SUCRA: 71.9%), contrasting with minimal therapeutic benefit from usual care (SUCRA: 3.0%). The therapeutic hierarchy for Modified Barthel Index enhancement, per SUCRA metrics, was: CCNEMS (71.9%) = LFES (71.9%) > taVNS+tDCS (71.7%) > rTMS (70.6%) > 4-ch FES (62.5%) > TENS (60.5%) > NEMS (59.7%) > taVNS (56.9%) > FES + tDCS (53.3%) > tDCS (52.2%) > 2-ch FES (46.3%) > FES (44.8%) > FES-Cycling (41.8%) > TEAS (41.5%) > MJL-WFES (41.0%) > Placebo (19.7%) > UC (3.0%).

3.5.4 10MWT

A total of 11 studies involving 946 subjects reported 10-meter walk test (10MWT) outcomes. Interventions included: 1 LFES, 6 FES, 1 EMG-FES + FES, 1 EMG-FES, 1 TEAS+tDCS, 1 NEMS, 1 TENS, and 1 multi-ch FES. Low-frequency electrical stimulation (LFES) exhibited maximal efficacy in enhancing the area under the curve for 10-meter walk test performance (SUCRA: 66.2%), contrasting with minimal therapeutic benefit from neuroelectrical muscle stimulation (NEMS, SUCRA: 35.6%). The therapeutic hierarchy for 10-meter walk test enhancement, per SUCRA metrics, was: LFES (66.2%) > EMG-FES + FES (57.2%) > multi-ch FES (56.9%) > TEAS+tDCS (50.9%) > usual care (UC, 51.2%) > EMG-FES (47.9%) > TENS (46.0%) > FES (38.2%) > NEMS (35.6%).

3.5.5 FAC

A total of 9 studies involving 715 subjects reported 10-meter walk test (10MWT) outcomes. Interventions included: 3 FES, 1 tDCS, 1 FES-Cycling, 1 4-ch FES, 1 2-ch FES, 1 TEAS+tDCS, 1 NEMS, 1 multi-ch FES, and 1 LFES. Transcranial direct current stimulation (tDCS) exhibited maximal efficacy in enhancing the area under the curve for Functional Ambulation Category measurements (SUCRA: 99.7%), contrasting with minimal therapeutic benefit from low-frequency electrical stimulation (LFES, SUCRA: 0.8%). The therapeutic hierarchy for Functional Ambulation Category enhancement, per SUCRA metrics, was: tDCS (99.7%) > FES-Cycling (82.0%) > 4-ch FES (68.1%) > multi-ch FES (60.2%) > FES (51.9%) = TEAS+tDCS (51.9%) > NEMS (50.6%) > usual care (UC, 18.3%) > 2-ch FES (16.5%) > LFES (0.8%).

3.6 Adverse reactions

The included studies reported relatively few adverse events. A single study reported 7 incidents of falls and one case of femoral fracture in the functional electrical stimulation (FES) cohort following intervention, whereas the control group exhibited 2 falls. One publication indicated that 2 participants in the tDCS group and 2 in the sham stimulation group reported pruritus, concurrently 2 control subjects described paresthesia. Overall, electrical stimulation demonstrated a favorable safety profile.

3.7 Publication bias

To comprehensively evaluate potential publication bias, we applied an integrated analytic framework for outcomes with at least 10 contributing studies. This approach combined contour-enhanced funnel plots, Egger and Begg tests, and the trim-and-fill procedure. For the FMA-L outcome, the results were discordant: Egger’s test (p = 0.010), Begg’s test (p = 0.045), and the contour-enhanced funnel plot all suggested a risk of publication bias, whereas the trim-and-fill method did not impute any missing studies. This inconsistency may reflect the substantial heterogeneity within the evidence network, indicating that the observed funnel plot asymmetry likely reflects a mixture of true variability and potential bias (Figure 5). By contrast, all other outcomes (BBS: p = 0.390/0.220; MBI: p = 0.105/0.186; 10MWT: p = 0.861/0.681; FAC: p = 0.618/0.920) showed non-significant test results and displayed symmetrical funnel plots, collectively indicating a low risk of publication bias (Figure 6). Regarding the implications for the NMA, the effect estimate for FMA-L should be interpreted with caution; however, any potential bias pertains only to a subset of the evidence network. The consistently low risk of bias across the remaining key outcomes provides robust support for the SUCRA-based ranking results. Taken together, although publication bias may attenuate the precision of the FMA-L estimates, it does not overturn the overarching conclusions regarding the relative effectiveness of the evaluated interventions.

Figure 5

Side-by-side funnel plots display publication bias data. The left plot shows the original data with 62 studies, while the right plot shows data after applying the trim and fill method with no additional studies imputed. Both plots chart standard error against effect size (Hedges' g).

Comparison of the funnel plot for FMA-L score following trim-and-fill analysis.

Figure 6

Four funnel plots labeled A, B, C, and D show the effect size centered at a comparison-specific pooled effect versus the standard error of effect size. Each plot contains colored dots and lines. Plots A and B feature scattered data points with distinct colored lines. Plots C and D show more concentrated data with lines indicating trends. Each plot includes dashed funnel guidelines and a central vertical line.

The funnel plot for all outcomes. (A) BBS score; (B) MBI score; (C) 10MWT; (D) FAC score.

4 Discussion

This study included 85 RCTs, involving 18 electrical stimulation modalities and 23 distinct stimulation protocols. Departing from conventional meta-analytical approaches, this investigation implemented network meta-analysis via Stata 18.0 and R 4.4.3 to holistically assess 23 electrical stimulation protocols across 18 modalities, evaluating efficacy/safety for post-stroke lower limb dysfunction through validated outcome measures (FMA-L, BBS, MBI, 10MWT, FAC). The FMA-L instrument quantitatively assesses limb motor control proficiency, with particular emphasis on evaluating the integrity of isolated joint movements, movement coordination, and reflex-mediated motor integration as indicators of neuromotor quality. The BBS scoring system monitors static and dynamic balance capabilities, providing critical data for fall risk prediction and balance training. The MBI provides a comprehensive assessment of ADL, with particular emphasis on quantifying autonomy during functional transfers, ambulation, and stair negotiation. Its aggregate score constitutes a pivotal metric for determining self-care capacity and discharge readiness. The 10MWT objectively quantifies functional walking speed, while the FAC assesses adaptability to different walking environments.

Based on SUCRA value analysis, EMG-FES combined with conventional FES demonstrated optimal efficacy in improving lower limb motor function in stroke patients (SUCRA = 89.0%). Its superior therapeutic effect stems from a synergistic “proactive neural drive + targeted functional remodeling” progressive rehabilitation pathway. EMG-FES establishes a closed-loop feedback system by detecting residual electromyographic signals to trigger electrical stimulation. The system operates via real-time synchronization of efferent motor commands with afferent proprioceptive feedback, conforming to Hebbian plasticity mechanisms that potentiate neural circuit reorganization through temporally correlated activation (33–36). Conventional FES precisely activates paralyzed or weakened lower limb muscles through electrical stimulation, inducing contractions that simulate natural movement patterns. This stimulation enhances motor unit recruitment and improves muscle co-contraction capacity, thereby optimizing key gait components (37, 38). EMG-FES establishes the neurophysiological substrate for recovery through neural drive mechanisms, while conventional FES concurrently enables precision neuromuscular remodeling and functional re-education. This dual synergy of neural reconstruction and motor control optimization collectively drives significant functional restoration, offering a novel rehabilitation strategy for post-stroke motor dysfunction. NMA indicated Multi-ch FES yielded significantly greater therapeutic efficacy for gait balance rehabilitation (SUCRA = 85.6%) compared to conventional single-channel FES (SUCRA = 55.7%). As an innovative rehabilitation technology, Multi-ch FES utilizes independently controlled electrode channels to deliver synchronous or sequential electrical stimulation, activating multiple lower limb muscle groups for synergistic neuromuscular optimization (39). The intervention employs spatiotemporal precision modulation: spatial targeting of multiple neuromuscular sites coupled with temporally phased stimulation synchronized to gait phase transitions, achieving physiological rhythm fidelity (40–42). Compared to traditional single-channel FES, the multi-channel approach designs stimulation based on muscle synergy patterns, more naturally simulating physiological gait while improving both immediate and long-term kinematic parameters (43). Despite identical SUCRA values (71.9%), CCNEMS exhibited a substantially higher probability of being the optimal intervention (PreBest = 25.9%) compared to LFES (PreBest = 6.2%), confirming its statistical superiority across ranking metrics. Thus, CCNEMS shows SUCRA and optimal treatment probability (PreBest), establishing it as the optimal protocol for improving MBI in stroke patients with lower limb dysfunction. CCNEMS represents an advanced NEMS technology that induces targeted skeletal muscle contraction through precisely regulated electrical pulses (44, 45). The paradigm-shifting innovation resides in programmable current parameters that dynamically simulate physiological neural firing patterns, facilitating optimal neuroplastic adaptation (46). In summary, CCNEMS utilizes controlled electrical parameters to deliver neuromuscular stimulation, designed to enhance therapeutic efficacy, minimize adverse effects, and promote co-adaptation of central and peripheral neural systems (47, 48). LFES is a significant neuromuscular rehabilitation technique. It delivers low-frequency electrical currents (typically 1–100 Hz) through surface electrodes to stimulate target neuromuscular tissues, aiming to elicit muscle contractions or modulate neural activity for functional improvement. LFES employs periodic pulsed currents (1–100 Hz) delivered transcutaneously to activate motor neurons (49, 50), effectively generating functional contractions in paralyzed muscles through direct stimulation of motor nerves or muscle fibers. Optimal efficacy occurs at 20–30 Hz (51), balancing effective muscle activation with minimal fatigue induction while demonstrating superior patient tolerance compared to higher-frequency protocols (49). Additionally, LFES specifically addresses gait abnormalities like foot drop and propulsion deficits. It potentiates neuroplasticity through enhanced corticospinal excitability and functional reorganization of motor cortical areas, establishing central mechanisms for sustainable gait rehabilitation (52–55). These synergistic mechanisms collectively enhance walking ability, evidenced by optimized 10MWT performance including increased speed, improved gait patterns, and enhanced endurance. Robust statistical confirmation (SUCRA = 66.2%) demonstrates LFES’s significant efficacy in enhancing ambulatory velocity as measured by the 10MWT. tDCS is a non-invasive brain stimulation technique proven to be a promising neurorehabilitation intervention (56). Its primary mechanism involves applying weak direct current (typically 1–2 mA) through scalp electrodes to modulate neurogenic excitability networks in both affected and unaffected hemispheres post-stroke (57–59). By regulating cortical excitability via low-intensity currents, tDCS promotes neuroplasticity, with targeted modulation of motor and cerebellar cortices potentially improving lower limb motor function. Studies demonstrate that Anodal tDCS potentiates lesioned-hemisphere excitability, whereas cathodal tDCS suppresses pathological contralateral hyperactivity, remodeling corticospinal transmission via LTP mechanisms while activating cerebellar-cortical pathways for motor coordination optimization (60–62). The exceptional SUCRA value (99.7%) derived from FAC assessment provides definitive statistical evidence of tDCS’s absolute superiority as the optimal intervention for post-stroke lower limb rehabilitation.

This study has several limitations. The majority of included studies omitted reporting on participant and outcome assessor blinding procedures, creating potential performance and detection bias that compromises methodological rigor. Significant inter-study variations in stimulation parameters (intensity/location) represent a probable source of clinical and methodological heterogeneity. Constraints of original studies precluded detailed subgroup analysis of disease duration and treatment cycles. Insufficient blinding implementation in most trials may have increased bias risk. Limiting to English/Chinese studies could overlook important evidence, and statistical patterns suggest negative results might be missing from the analysis. Future large-scale, high-quality studies are needed to validate these findings.

5 Conclusion

The extant literature substantiates that electromagnetic stimulation yields statistically and clinically significant improvements across core rehabilitation domains: limb motor control (FMA-L), static/dynamic balance (BBS), activities of daily living (MBI), functional gait speed (10MWT), and ambulatory capacity (FAC) in post-stroke lower limb dysfunction. Methodological constraints and sample size limitations necessitate future investigation through rigorously designed trials featuring multimodal outcome batteries and methodologically robust multi-center randomized controlled trials.

Statements

Data availability statement

The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.

Author contributions

JL: Software, Writing – original draft, Formal analysis, Methodology, Visualization, Investigation, Conceptualization, Writing – review & editing, Data curation. FZ: Software, Writing – review & editing, Writing – original draft, Data curation, Formal analysis, Methodology. ZP: Software, Data curation, Writing – review & editing, Writing – original draft, Formal analysis, Methodology. SW: Methodology, Formal analysis, Data curation, Writing – original draft, Software, Writing – review & editing. DL: Software, Data curation, Writing – review & editing, Writing – original draft, Formal analysis, Methodology. ST: Methodology, Data curation, Formal analysis, Writing – review & editing, Writing – original draft, Software. HS: Resources, Writing – review & editing, Conceptualization, Validation, Supervision, Methodology, Writing – original draft.

Funding

The author(s) declare that no financial support was received for the research and/or publication of this article.

Acknowledgments

The authors thank the patients, the investigators and their teams who took part in the clinical trials included in this systematic review and meta-analysis.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Gen AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2025.1682671/full#supplementary-material

    Glossary

  • ADL

    Activities of daily living

  • NMA

    Network meta-analysis

  • PreBest

    Optimal treatment probability

  • SUCRA

    Surface under the cumulative ranking analysis

  • MD

    Mean difference

  • 95%CI

    95% confidence intervals

  • REM

    Random-EFFECTS MODELS

  • MeSH

    Medical subject headings

  • RCTs

    Randomized Controlled Trials

  • FMA-L

    Fugl-Meyer assessment for lower extremity

  • BBS

    Berg balance scale

  • MBI

    Modified Barthel index

  • 10MWT

    10-Meter walk test

  • FAC

    Functional ambulation category

  • FES

    Functional electrical stimulation

  • 4-ch FES

    Quad-channel FES

  • 2-ch FES

    Dual-channel FES

  • Multi-ch FES

    Multi-channel FES

  • tDCS

    Transcranial direct current stimulation

  • rTMS

    repetitive transcranial magnetic stimulation

  • TENS

    Transcutaneous electrical nerve stimulation

  • TEAS

    Transcutaneous acupoint electrical stimulation

  • NEMS

    Neuromuscular electrical stimulation

  • LFES

    Low-frequency electrical stimulation

  • IFES

    Intermediate-frequency electrical

  • DFES

    Deep muscle electrical stimulation

  • CCNEMS

    Controllable current neuromuscular electrical stimulation

  • FNS

    Fastigial nucleus stimulation

  • MJL-WFES

    Multi-joint linked wearable FES

  • EMG

    Muscle-triggered electrical stimulation

  • taVNS

    Transcutaneous auricular vagus nerve stimulation

References

  • 1.

    Romano F Formenti D Cardone D Russo EF Castiglioni P Merati G et al . Data-driven identification of stroke through machine learning applied to complexity metrics in multimodal electromyography and kinematics. Entropy (Basel). (2024) 26:e26070578. doi: 10.3390/e26070578,

  • 2.

    Chen S Gao J Zhou Y Zheng B Liu Y Cao M et al . Implications of neuromuscular electrical stimulation on gait ability, balance and kinematic parameters after stroke: a systematic review and meta-analysis. J Neuroeng Rehabil. (2024) 21:164. doi: 10.1186/s12984-024-01462-2,

  • 3.

    Tang Q Yang X Sun M He M Sa R Zhang K et al . Research trends and hotspots of post-stroke upper limb dysfunction: a bibliometric and visualization analysis. Front Neurol. (2024) 15:1449729. doi: 10.3389/fneur.2024.1449729,

  • 4.

    Luo X . Effects of motor imagery-based brain-computer interface-controlled electrical stimulation on lower limb function in hemiplegic patients in the acute phase of stroke: a randomized controlled study. Front Neurol. (2024) 15:1394424. doi: 10.3389/fneur.2024.1394424,

  • 5.

    Hohsoh N Sanghan T Chong DYR Stojanovic G Chatpun S . Comparative electromyography analysis of subphase gait disorder in chronic stroke survivors. PeerJ. (2024) 12:e18473. doi: 10.7717/peerj.18473,

  • 6.

    Warenczak-Pawlicka A Lisinski P . Is the assessment of the non-paretic lower limb in patients after stroke important when planning rehabilitation?Sensors (Basel). (2025) 25:1082. doi: 10.3390/s25041082,

  • 7.

    Zheng K Li L Zhou Y Gong X Zheng G Guo L . Optimal proprioceptive training combined with rehabilitation regimen for lower limb dysfunction in stroke patients: a systematic review and network meta-analysis. Front Neurol. (2024) 15:1503585. doi: 10.3389/fneur.2024.1503585,

  • 8.

    Gao L Jin Q Zhou C Huang Y Liu J Chen Y et al . Effect of task-oriented biomechanical perception-balance training on motor gait in stroke patients with hemiplegia. Altern Ther Health Med. (2024) 30:2904.

  • 9.

    Miraglia F Pappalettera C Barbati SA Podda MV Grassi C Rossini PM et al . Brain complexity in stroke recovery after bihemispheric transcranial direct current stimulation in mice. Brain Commun. (2024) 6:fcae137. doi: 10.1093/braincomms/fcae137,

  • 10.

    Fang Y Li J Liu S Wang Y Li J Yang D et al . Optimization of electrical stimulation for the treatment of lower limb dysfunction after stroke: A systematic review and Bayesian network meta-analysis of randomized controlled trials. PLoS One. (2023) 18:e0285523. doi: 10.1371/journal.pone.0285523,

  • 11.

    Chu F Gao L Zhou J Jia F Chen J Tang W et al . Transcranial direct current stimulation combined with isokinetic strength training to improve lower limb motor function in chronic stroke survivors: A randomized controlled study. PM R. (2025). doi: 10.1002/pmrj.13429,

  • 12.

    Liu Z Wang L Hou M Li S Zhang H Li H . Combined therapy with contralateral controlled functional electrical stimulation and transcranial direct current stimulation for early post-stroke hand dysfunction. Biomed Eng Online. (2025) 24:81. doi: 10.1186/s12938-025-01417-1,

  • 13.

    Zhou Y Yang S Li D Li W Yang C Huo H et al . Peripheral electrical stimulation on motor function and activities of daily living after stroke: A systematic review and network Meta-analysis. Arch Phys Med Rehabil. (2025) 106:125866. doi: 10.1016/j.apmr.2025.01.466,

  • 14.

    Debeuf R De Vlieger D Defour A Feyen K Guida S Cuypers L et al . Electrotherapy in stroke rehabilitation can improve lower limb muscle characteristics: a systematic review and meta-analysis. Disabil Rehabil. (2025) 47:1632. doi: 10.1080/09638288.2024.2334444,

  • 15.

    Liu D Jiang S Li J Jai J Sun F . Analysis of the effect of functional electrical stimulation on lower limb function in stroke patients with hemiplegia. Elect J Clin Med Literat. (2020) 7:43. doi: 10.16281/j.cnki.jocml.2020.16.035

  • 16.

    Jung KS Jung JH In TS Cho HY . Effectiveness of heel-raise-lower exercise after transcutaneous electrical nerve stimulation in patients with stroke: A randomized controlled study. J Clin Med. (2020) 9:3532. doi: 10.3390/jcm9113532,

  • 17.

    Liu Y Lin Q Chen D Li Z Ma Q Yang H . Efficacy study of functional electrical stimulation synchronous lower limb rehabilitation robot on ankle function in patients with foot droop after cerebral apoplexy. China Mod Med. (2021) 28:4650. doi: 10.3969/j.issn.1674-4721.2021.13.012

  • 18.

    Peng Y Zhang J Zhang T Zhang S Li G . Effect of transcutaneous accupoint electrical stimulation on motor function recovery of the lower extremity of stroke patients. Guangzhou Yi Xue. (2015) 46:1922. doi: 10.3969/j.issn.1001-1242.2007.10.010

  • 19.

    You G Liao L Liang H Shi H . Effectiveness of functional electrical stimulation on motor and functional recovery of the lower extremity in subject with early stroke: a randomized controlled trial. China Pract Med. (2013) 8:47. doi: 10.14163/j.cnki.11-5547/r.2013.03.197

  • 20.

    You G Yan T Christina WY . Effectiveness of functional electrical stimulation on functional recovery of the lower extremity in subject with early stroke: a randomized controlled trial. Chin J Rehabil Med. (2007):86770. doi: 10.3969/j.issn.1673-7555.2013.03.002

  • 21.

    Chen H Zheng X Lyu X Ding L He L Liu C et al . A controlled study on the effect of synchronized transcranial direct current stimulation and multi-channel functional electrical stimulation on lower limb motor function in stroke patients with hemiplegia. Chin J Rehabil Med. (2021) 36:122732.

  • 22.

    Matsumoto S Shimodozono M Noma T Miyara K Onoda T Ijichi R et al . Effect of functional electrical stimulation in convalescent stroke patients: A multicenter, randomized controlled trial. J Clin Med. (2023) 12:2638. doi: 10.3390/jcm12072638,

  • 23.

    J L . Analysis of the application of low-frequency electrical stimulation combined with motor rehabilitation functional exercise in stroke patients with hemiplegia. Chin Sci J Database (Citat Edit) Med Health. (2023), 2023:112115.

  • 24.

    Shen Y Chen L Zhang L Hu S Su B Qiu H et al . Effectiveness of a novel Contralaterally controlled neuromuscular electrical stimulation for restoring lower limb motor performance and activities of daily living in stroke survivors: A randomized controlled trial. Neural Plast. (2022) 2022:19. doi: 10.1155/2022/5771634,

  • 25.

    Wang L Wang L Wang Z Gao F Wu J Tang H . Clinical effect analysis of wearable sensor technology-based gait function analysis in post-transcranial magnetic stimulation stroke patients. Sensors (Basel). (2024) 24:3051. doi: 10.3390/s24103051,

  • 26.

    Jin G Liu H . Effect of multi channel functional electrical stimulation on walking test and DTI scan in patients with stroke. J Shandong First Med Univ Shandong Acad Med Sci. (2017) 38:1657. doi: 10.3969/j.issn.1004-7115.2017.02.016

  • 27.

    Liu J Wang W Xu D Wang N Wu Y . Effect of multi-joint functional electrical stimulation combined with conventional rehabilitation therapy on lower limb motor function of patients with stroke. Rehabilit Med. (2024) 34:34954. doi: 10.3724/SP.J.1329.2024.04006

  • 28.

    Bilek F Deniz G Ercan Z Cetisli Korkmaz N Alkan G . The effect of additional neuromuscular electrical stimulation applied to erector spinae muscles on functional capacity, balance and mobility in post-stroke patients. NeuroRehabilitation. (2020) 47:1819. doi: 10.3233/NRE-203114,

  • 29.

    Yan G Zang D Wang Z . The effect of low-frequency electrical stimulation of peripheral nerves on curative efficacy in hemiplegic patients with cerebral infarction complicated by hemisensory impairment. Chin J Phys Med Rehabil. (2009) 31:3979. doi: 10.3760/cma.j.issn.0254-1424.2009.06.012

  • 30.

    Tan Z Liu H Yan T Jin D He X Zheng X et al . The effectiveness of functional electrical stimulation based on a normal gait pattern on subjects with early stroke: a randomized controlled trial. Biomed Res Int. (2014) 2014:545408. doi: 10.1155/2014/545408,

  • 31.

    Wang Z Bai D Ma J . Effects of TEAS combined with tDCSS on spasticity and motor function in ischemic stroke with spastic hemiplegia. J Clin Exp Med. (2024) 23:11614. doi: 10.3969/j.issn.1671-4695.2024.11.011

  • 32.

    Zhang XH Gu T Liu XW Han P Lv HL Wang YL et al . The effect of transcranial direct current stimulation and functional electrical stimulation on the lower limb function of stroke patients. Front Neurosci. (2021) 15:685931. doi: 10.3389/fnins.2021.685931,

  • 33.

    Khan MA Fares H Ghayvat H Brunner IC Puthusserypady S Razavi B et al . A systematic review on functional electrical stimulation based rehabilitation systems for upper limb post-stroke recovery. Front Neurol. (2023) 14:1272992. doi: 10.3389/fneur.2023.1272992,

  • 34.

    Krueger J Krauth R Reichert C Perdikis S Vogt S Huchtemann T et al . Hebbian plasticity induced by temporally coincident BCI enhances post-stroke motor recovery. Sci Rep. (2024) 14:18700. doi: 10.1038/s41598-024-69037-8,

  • 35.

    Covarrubias-Escudero F Appelgren-Gonzalez JP Nunez-Saavedra G Urrea-Baeza D Varas-Diaz G . Enhancing gait biomechanics in persons with stroke: the role of functional electrical stimulation on step-to-step transition. Physiother Res Int. (2025) 30:e70080. doi: 10.1002/pri.70080,

  • 36.

    Liu Z Huo W Yu Z Bentley P Bull AMJ Vaidyanathan R . Continuous estimation of FES-induced neuromuscular fatigue using Mechanomyography signals. IEEE J Biomed Health Inform. (2025) 29:796982. doi: 10.1109/JBHI.2025.3580560,

  • 37.

    AlAbdulwahab SS Aldhaferi AS Alsubiheen AM Alharbi SH Alotaibi FH Alghamdi MA et al . The effects of functional electrical stimulation of hip abductor and tibialis anterior muscles on standing and gait characteristics in patients with stroke. J Clin Med. (2025) 14:2309. doi: 10.3390/jcm14072309,

  • 38.

    Donlin MC Higginson JS . Adaptive functional electrical stimulation delivers stimulation amplitudes based on real-time gait biomechanics. J Med Device. (2024) 18:021002. doi: 10.1115/1.4065479,

  • 39.

    Berkelmans S Dominici N Afschrift M Bruijn S Janssen TWJ . Feasibility and safety of automated multi-channel FES-assisted gait training in incomplete spinal cord injury. J Rehabil Med. (2025) 57:jrm42638. doi: 10.2340/jrm.v57.42638,

  • 40.

    Lu C Ge R Tang Z Fu X Zhang L Yang K et al . Multi-Channel FES gait rehabilitation assistance system based on adaptive sEMG modulation. IEEE Trans Neural Syst Rehabil Eng. (2023) 31:365263. doi: 10.1109/TNSRE.2023.3313617,

  • 41.

    Li Y Yang X Zhou Y Chen J Du M Yang Y . Adaptive stimulation profiles modulation for foot drop correction using functional electrical stimulation: A proof of concept study. IEEE J Biomed Health Inform. (2021) 25:5968. doi: 10.1109/JBHI.2020.2989747,

  • 42.

    Kim SJ Worthy A Lee B Jafari S Dyke O Cho J et al . Adapting spatiotemporal gait symmetry to functional electrical stimulation during treadmill walking. PLoS One. (2024) 19:e0312285. doi: 10.1371/journal.pone.0312285,

  • 43.

    Bala S Vishnu VY Joshi D . Muscle synergy-based functional electrical stimulation reduces muscular fatigue in post-stroke patients: A systematic comparison. IEEE Trans Neural Syst Rehabil Eng. (2023) 31:285871. doi: 10.1109/TNSRE.2023.3290293,

  • 44.

    Greve KR Joseph CF Berry BE Schadl K Rose J . Neuromuscular electrical stimulation to augment lower limb exercise and mobility in individuals with spastic cerebral palsy: A scoping review. Front Physiol. (2022) 13:951899. doi: 10.3389/fphys.2022.951899,

  • 45.

    Sharma MK Chaudhary S Shenoy S . Development and testing of range of motion driven motor unit recruitment device for knee rehabilitation: A randomized controlled trial. MethodsX. (2025) 14:103382. doi: 10.1016/j.mex.2025.103382,

  • 46.

    Paz IA Sonda FC Frohlich M Durigan JLQ Vaz MA . Kilohertz frequency alternating current induces less evoked torque and less neuromuscular efficiency than pulsed current in healthy people: a randomized crossover trial. J Sport Rehabil. (2023) 32:5408. doi: 10.1123/jsr.2022-0159,

  • 47.

    Yuan R Peng Y Ji R Zheng Y . Comparison of the activation level in the sensorimotor cortex between motor point and proximal nerve bundle electrical stimulation. J Neural Eng. (2024) 21:026029. doi: 10.1088/1741-2552/ad3850,

  • 48.

    Guo C Sui Y Xu S Zhuang R Zhang M Zhu S et al . Contralaterally controlled neuromuscular electrical stimulation-induced changes in functional connectivity in patients with stroke assessed using functional near-infrared spectroscopy. Front Neural Circuits. (2022) 16:955728. doi: 10.3389/fncir.2022.955728,

  • 49.

    Tenberg S Weinig J Niederer D Vogt L Leisse M Muller S . Effects of kilohertz versus low-frequency electrical stimulation of the wrist extensors in patients after stroke: A randomized crossover trial. PM R. (2025) 17:105568. doi: 10.1002/pmrj.13368,

  • 50.

    Xia X Dong X Huo H Zhang Y Song J Wang D . Clinical study of low-frequency acupoint electrical stimulation to improve thumb-to-finger movements after stroke: A randomized controlled trial. Medicine (Baltimore). (2023) 102:e35755. doi: 10.1097/MD.0000000000035755,

  • 51.

    He R Dong Y Li Y Zheng M Peng S Tong RK et al . Therapeutic and orthotic effects of an adaptive functional electrical stimulation system on gait biomechanics in participants with stroke. J Neuroeng Rehabil. (2025) 22:62. doi: 10.1186/s12984-025-01577-0,

  • 52.

    He W Yaning L Shaohong Y . Effect of electrical stimulation in the treatment on patients with foot drop after stroke: a systematic review and network meta-analysis. J Stroke Cerebrovasc Dis. (2025) 34:108279. doi: 10.1016/j.jstrokecerebrovasdis.2025.108279,

  • 53.

    Cheng HL Lin CH Tseng SH Peng CW Lai CH . Effectiveness of repetitive transcranial magnetic stimulation combined with visual feedback training in improving neuroplasticity and lower limb function after chronic stroke: a pilot study. Biology (Basel). (2023) 12:515. doi: 10.3390/biology12040515,

  • 54.

    Shu X Yu H Zhou Y Zhou S Chen B . Clinical study on low-frequency repetitive transcranial magnetic stimulation for the treatment of walking dysfunction following stroke through three-dimensional gait analysis. Psychogeriatrics. (2024) 24:18294. doi: 10.1111/psyg.13058,

  • 55.

    Comino-Suarez N Moreno JC Gomez-Soriano J Megia-Garcia A Serrano-Munoz D Taylor J et al . Transcranial direct current stimulation combined with robotic therapy for upper and lower limb function after stroke: a systematic review and meta-analysis of randomized control trials. J Neuroeng Rehabil. (2021) 18:148. doi: 10.1186/s12984-021-00941-0,

  • 56.

    Ishikuro K Hattori N Otomune H Furuya K Nakada T Miyahara K et al . Neural mechanisms of neuro-rehabilitation using transcranial direct current stimulation (tDCS) over the front-polar area. Brain Sci. (2023) 13:1604. doi: 10.3390/brainsci13111604,

  • 57.

    Qi S Cao L Wang Q Sheng Y Yu J Liang Z . The physiological mechanisms of transcranial direct current stimulation to enhance motor performance: A narrative review. Biology (Basel). (2024) 13:790. doi: 10.3390/biology13100790,

  • 58.

    Klees-Themens G Theoret H . The effects of transcranial direct current stimulation on corticospinal excitability: A systematic review of nonsignificant findings. Eur J Neurosci. (2023) 58:307497. doi: 10.1111/ejn.16073,

  • 59.

    Qurat Ul A Ahmad Z Ishtiaq S Ilyas S Shahid I Tariq I et al . Short term effects of anodal cerebellar vs. anodal cerebral transcranial direct current stimulation in stroke patients, a randomized control trial. Front Neurosci. (2022) 16:1035558. doi: 10.3389/fnins.2022.1035558,

  • 60.

    Lima JPS Silva LA Delisle-Rodriguez D Cardoso VF Nakamura-Palacios EM Bastos-Filho TF . Unraveling transformative effects after tDCS and BCI intervention in chronic post-stroke patient rehabilitation-an alternative treatment design study. Sensors (Basel). (2023) 23:9302. doi: 10.3390/s23239302,

  • 61.

    Hamajima H Gomez-Tames J Uehara S Otaka Y Tanaka S Hirata A . Computation of group-level electric field in lower limb motor area for different tDCS montages. Clin Neurophysiol. (2023) 150:6978. doi: 10.1016/j.clinph.2023.03.009,

  • 62.

    Salazar CA Feng W Bonilha L Kautz S Jensen JH George MS et al . Transcranial direct current stimulation for chronic stroke: is neuroimaging the answer to the next leap forward?J Clin Med. (2023) 12:2601. doi: 10.3390/jcm12072601,

  • 63.

    Liang X Li N Pan F Zhang X Duan Y . Effects of tDCS combined with electromyography biofeedback on limb function, motor function and dynamic postural stability in elderly patients with hemiplegia after cerebral infarction. Chin J Brain Dis Rehabilit (Elect Edit). (2023) 13:906. doi: 10.3877/cma.j.issn.2095-123X.2023.02.004

  • 64.

    Sautho L . (2021). The effect of functional electrical stimulation cycling on hip flexion function in patients with early stroke. Master's Degree. Zhengzhou University.

  • 65.

    Wei J Wang X . Effect of BRT combined with NMES on balance and neurological function in elderly stroke patients with hemiplegia. Chin J Geriatr Heart Brain Vessel Dis. (2024) 26:132933.

  • 66.

    Hu B . Clinical observation of low-frequency electrical stimulation combined with basic rehabilitation in the treatment of stroke patients with hemiplegia. Health Prot Promot. (2022) 22:17324.

  • 67.

    Sun X Chen Y Yan Y Li R Lu X . Effect of low frequency electrical stimulation combined with rehabilitation training on stroke patients with hemiplegia, motor function and self-efficacy. Prog Modern Biomed. (2023) 23:27502753,2759. doi: 10.13241/j.cnki.pmb.2023.14.029

  • 68.

    Hong Y Xue K Xiao P Pan X Xue C . Low frequency electrical stimulation treatment on stroke hemiplegia and its influences on peripheral nerve electrophysiology and morphology. Guangzhou Med J. (2021) 52:15. doi: 10.3969/j.issn.1000-8535.2021.02.001

  • 69.

    Zhang S Lin Q . Effect of low-frequency muscle electrical stimulator combined with rehabilitation training on limb motor function in patients with hemiplegic after stroke. Reflexol Rehabili Med. (2023) 4:458.

  • 70.

    Dong Y Han Y . Therapeutic effect of low-frequency pulse electrical stimulation combined with limb rehabilitation exercises on post-stroke hemiplegic patients. Lab Med Clin. (2022) 19:270710. doi: 10.3969/j.issn.1672-9455.2022.19.031

  • 71.

    Li L . The effect of low-frequency pulse electrical stimulation combined with limb rehabilitation training on neuromotor function in stroke patients with hemiplegia. Modern Med Health Res Elect J. (2024) 8:1424. doi: 10.3969/j.issn.2096-3718.2024.05.046

  • 72.

    Liang S . Analysis of the effect of low-frequency rTMS combined with FES in patients with ischemic stroke. Trad Chin Med Rehabilit. (2022) 13:102. doi: 10.19787/j.issn.1008-1879.2022.06.004

  • 73.

    Zong T . Influence of Du acupoint electrical stimulation on limb spasticity after cerebral infarction and motor function. Liaoning J Tradit Chin Med. (2012) 39:13913. doi: 10.13192/j.ljtcm.2012.07.198.zongt.021

  • 74.

    Wang L Du Z Guan Z Yu R Zeng Y . Effects of multichannel functional electrical stimulation combined with limb linkage training on lower limb motor function and walking function in stroke patients. J Mod Med Health. (2023) 39:36326. doi: 10.3969/j.issn.1009-5519.2023.21.007

  • 75.

    Shi Z Zhao X . Effects of multi-channel functional electrical stimulation on limb linkage on walking function in convalescent patients with ischemic stroke. Reflexol Rehabili Med. (2023) 4:10912.

  • 76.

    Wang Y Li Z Guo G Hao D Fan J . The impact of functional electrical stimulation restorative therapy with cycling on lower limb electromyographic signals in stroke patients. Chin J Rehabil Med. (2018) 33:5658. doi: 10.3969/j.issn.1001-1242.2018.05.014

  • 77.

    Ren H Guo X Xu M Li H Pan T . The effect of functional electrical stimulation combined with EMG biofeedback therapy on lower limb motor function in post-stroke hemiplegic patients. Chin J Phys Med Rehabil. (2018) 40:4213. doi: 10.3760/cma.j.issn.0254-1424.2018.06.005

  • 78.

    Xu C Guo Y Sun Z . Impact of functional electrical stimulation rehabilitation trainiii gongait symmetry of convalescent stroke patients with hemiplegia. Clin Med Eng. (2024) 31:4112. doi: 10.3969/j.issn.1674-4659.2024.04.0411

  • 79.

    Chen D Tang D Wen S Huang Y Xu H . Observation on the effect of modified compulsory exercise therapy combined with functional electrical stimulation on the recovery of lower extremity function in stroke patients. J Baotou Med Coll. (2020) 36:2223+36. doi: 10.16833/j.cnki.jbmc.2020.05.007

  • 80.

    Ding B Mao W Wu S Mao X Zhang M . Research on the effect of functional electrical stimulation combined with Bobath therapy on stroke patients with hemiplegia. Pract J Card Cereb Pneumal Vasc Dis. (2022) 30:1059. doi: 10.12114/j.issn.1008-5971.2022.00.151

  • 81.

    Mag Q Song D Qie S . The impact of functional electrical stimulation combined with four-limb linkage training on lower limb function and walking ability in stroke patients. Rehabilit Med. (2016) 26:103. doi: 10.3724/SP.J.1329.2016.06010

  • 82.

    Sun B Zhou Z Zhong Y . Clinical effect of functional electrical stimulation on hemiplegia in patients with cerebral apoplexy. Chin J Pract Nerv Dis. (2020) 23:10959. doi: 10.12083/SYSJ.2020.12.250

  • 83.

    Tan Z Liu H Yan T Jin D He X Zheng X et al . A randomized controlled trial of functional electrical stimulation on lower limb function in stroke patients. Contemp Med. (2014) 20:6969,70. doi: 10.3969/j.issn.1009-4393.2014.3.043

  • 84.

    Xu Y Hou T Qu Y Zhang H Li J . The impact of gait pattern-based single-joint versus dual-joint functional electrical stimulation on lower limb function and cerebral diffusion tensor imaging in stroke patients. Chin J Rehabil Med. (2023) 38:6649. doi: 10.3870/zgkf.2023.11.005

  • 85.

    Ma Y Wang W He Q Guo X . The efficacy of transcutaneous electrical nerve stimulation on lower limb spasticity and movement function in stroke patients with hemiplegia. Chin J Brain Dis Rehabilit (Elect Edit). (2011) 1:1836. doi: 10.3877/cma.j.issn.2095-123X.2011.02.013

  • 86.

    Cao L He Y . A clinical study on transcutaneous electrical nerve stimulation combined with resistance training in post-stroke hemiplegic patients. Modern Med Health Res Elect J. (2022) 6:303.

  • 87.

    Chen C Li S Tang C Chen C Zhang X Wu Y et al . Effects of transcutaneous electrical acupoint stimulation on lower limb motor function and activities of daily living in stroke patients. Chin J Rehabil Med. (2016) 31:16870. doi: 10.3870/zgkf.2016.03.002

  • 88.

    Wang Q . The effect of transcutaneous acupoint electrical stimulation on rehabilitation nursing for hemiplegia in patients during stroke recovery. Health Care Today. (2023) 23:16613. doi: 10.3969/j.issn.1671-0223(s).2023.21.020

  • 89.

    Gong X Wang M Wu C Chen J Xiao Y Yang Y et al . Effect of galvanic vestibular stimulation on stroke patients with lateropulsion. Chin J Rehabil Theory Pract. (2024) 30:2106. doi: 10.12307/2025.202

  • 90.

    Zhang Q Liao D Zhong Z Lin L Zheng X Li Q et al . Effect of deep muscle stimulation combined with electromyographic biofeedback on the spasms of the triceps surae and gait changes after stroke. Chin J Tissue Eng Res. (2025) 29:38592. doi: 10.3969/j.issn.1006-7256.2021.07.020

  • 91.

    Qiu Z Wang J Zhang X Wang X Wang M . Effects of neuromuscular electrical stimulation combined with rehabilitation training on electromyography and lower extremity function in patients with lower extremity paralysis after stroke. Henan Med Res. (2022) 31:372932. doi: 10.3969/j.issn.1004-437X.2022.20.018

  • 92.

    Yang M Zhao X Li H . Effects of neuromuscular electrical stimulation combined with exercise therapy on balance function, daily living ability and nerve function in stroke patients with hemiplegia. Reflexol Rehabili Med. (2023) 4:7173,77.

  • 93.

    Wen X Zou Y Cao L . Application effect of neuromuscular electrical stimulation therapy instrument on stroke patient with hemiplegia. Acta Med Sin. (2021) 34:825. doi: 10.19296/j.cnki.1008-2409.2021-02-023

  • 94.

    Yan X . Efficacy of early rehabilitation training combined with neuromuscular electrical stimulation in the treatment of stroke patients with hemiplegia. Med Forum. (2023) 27:14850. doi: 10.19435/j.1672-1721.2023.02.048

  • 95.

    Zhang G Liu W . Effect of intermediate frequency pulse electrical stimulation combined with rehabilitation training on functional rehabilitation of stroke patients with hemiplegia. Reflexol Rehabili Med. (2023) 4:736.

  • 96.

    Zhang XH Liu JY Han P Wang YL Xiao P . Clinical efficacy of functional electrical stimulation-assisted rehabilitation cycling on the function of lower limbs in patients with stroke. Curr Neurovasc Res. (2021) 18:31823. doi: 10.2174/1567202618666211012094424,

  • 97.

    Hsu SP Lu CF Lin BF Tang CW Kuo IJ Tsai YA et al . Effects of bihemispheric transcranial direct current stimulation on motor recovery in subacute stroke patients: a double-blind, randomized sham-controlled trial. J Neuroeng Rehabil. (2023) 20:27. doi: 10.1186/s12984-023-01153-4,

  • 98.

    Wang L Wang L Wang Z Zhao H Wu J Gao F et al . Efficacy observation of combined transcutaneous vagus nerve stimulation and transcranial direct current stimulation on gait in 169 subacute stroke patients. J Rehabil Med. (2024) 56:jrm40348. doi: 10.2340/jrm.v56.40348,

  • 99.

    Dujovic SD Malesevic J Malesevic N Vidakovic AS Bijelic G Keller T et al . Novel multi-pad functional electrical stimulation in stroke patients: A single-blind randomized study. NeuroRehabilitation. (2017) 41:791800. doi: 10.3233/NRE-172153,

  • 100.

    Zheng X Chen D Yan T Jin D Zhuang Z Tan Z et al . A randomized clinical trial of a functional electrical stimulation mimic to gait promotes motor recovery and brain remodeling in acute stroke. Behav Neurol. (2018) 2018:110. doi: 10.1155/2018/8923520,

  • 101.

    Yang T Li X Lin Q Yang Q Xu L Gao Z et al . Effects of gait induced FES to function of lower limb and walking speed in stroke patients with foot droop. Chin J Rehabil Med. (2018) 33:1704. doi: 10.3969/j.issn.1001-1242.2018.02.009

  • 102.

    Xu J Ru K Yang F Qiu Y Li W Nu L et al . A randomized controlled trial of low-frequency electrical stimulation on motor function in acute stroke patients with hemiplegia. J Bingtuan Med. (2015) 46:234.

  • 103.

    Chen J Yang Z Mei Y . Effect of low frequency stimulation and rehabilitation training on stroke patients. Chin J Rehabil Theory Pract. (2006) 12:289. doi: 10.3969/j.issn.1006-9771.2006.01.012

  • 104.

    Zhou J Pan J Mao L . Effect of fastigial nucleus stimulation limbs motor function in acute cerebral infarction. Cardio-cerebrovasc Dis Prev Treat. (2003) 34:201. doi: 10.3969/j.issn.1009-816X.2003.01.009

  • 105.

    Xu D Wang W Liu J Fan W Chen Y Wu Y et al . The effects of multi-muscles co-contraction based functional electrical stimulation on the lower extremities' motor function among early stroke patients. Chin J Rehabil Med. (2019) 34:11627. doi: 10.3969/j.issn.1001-1242.2019.10.005

  • 106.

    Chen D Yan T Li G Li F Liang Q . Effect ofmulti—channel functional electrical stimulationon motor and functionaI recovery of the lower extremity in early stroke patients. Chin J Rehabil Med. (2013) 28:28991. doi: 10.3870/zgkf.2013.04.020

  • 107.

    Liu J Wang W Liang S Xu D Wu J Zhu Y . The impact of multi-channel functional electrical stimulation cycling training on walking function in stroke patients. Chin J Rehabil Med. (2021) 36:1825. doi: 10.3969/j.issn.1001-1242.2021.02.010

  • 108.

    Li G Zhu X Li X Ma J Feng H Shang X . Effects of functional electrical stimulation on lower limbs motor function of stroke patients with hemiplegia. Med Innovat China. (2019) 16:1303. doi: 10.3969/j.issn.1674-4985.2019.11.035

  • 109.

    Zhan S Zhu J Zheng L . Effects of functional electrical stimulation on balance function and clinical outcomes in patients with early-stroke hemiplegia. Tradit Chin Med Rehabilit. (2021) 12:212. doi: 10.19787/j.issn.1008-1879.2021.10.008

  • 110.

    Cai C Xu Y Li Z . Impacts of functional electrical stimulation combined with repetitive transcranial magnetic stimulation on hemiplegia patients with ischemic stroke. China Med Pharm. (2021) 11:15861. doi: 10.3969/j.issn.2095-0616.2021.12.042

  • 111.

    Yang L. (2017). The effects of electromyographic biofeedback treatmentcombing with rehabilitation training in improving limbs motorfunction of hemiplegic stroke patients. Master's Degree. Hebei Medical University.

  • 112.

    Zhao J Shi M Fan W Chen B Jin L . Rehabilitation effect of transcranial direct current stimulation on increased muscle tone after stroke and brain network mechanism. Clin Educ Gen Pract. (2023) 21:407409+380. doi: 10.13558/j.cnki.issn1672-3686.2023.005.007

  • 113.

    Guo T Liu J Guo Y . The effect of transcranial direct current stimulation on hemispatial neglect after stroke. Chin J Trauma Disabil Med. (2015) 2015:213. doi: 10.13214/j.cnki.cjotadm.2015.08.013

  • 114.

    Geng J Xia Y Niu C Zhu X Han L Wu W et al . The effect of combined transcranial direct current stimulation and functional electrical stimulation cycling on lower limb motor function in early-stroke patients. Chin J Phys Med Rehabil. (2021) 43:3115. doi: 10.3760/cma.j.issn.0254-1424.2021.04.005

  • 115.

    Cheng A Shen X Yang J . Effects of transcutaneous electric nerve stimulation combined with rehabilitative training on the recovery of memory and motor function in stroke patients. Chin J Tissue Eng Res. (2005) 9:157. doi: 10.3321/j.issn:1673-8225.2005.37.008

  • 116.

    Zhang H . Effect of transutaneous electrical nerve stimulation on acupuncture points on revovery of motor function in acute stroke patients. J Emerg Tradit Chin Med. (2013) 22:4256. doi: 10.3969/j.issn.1004-745X.2013.03.038

  • 117.

    Chen X Wang Y Wang J Wen H . The effect of low-frequency pulse electrical stimulation combined with limb rehabilitation exercises on limb motor function in post-stroke hemiplegic patients. Modern Med Health Res Elect J. (2025) 9:135. doi: 10.3969/j.issn.2096-3718.2025.03.005

  • 118.

    Wang P . The impact of deep muscle electrical stimulation technology combined with rehabilitation training on limb mobility and balance function in post-stroke hemiplegic patients. Pract Clin J Integ Tradit Chin Western Med. (2023) 23:5860. doi: 10.13638/j.issn.1671-4040.2023.10.016

  • 119.

    Yang Y . The effect of neuromuscular electrical stimulation on activities of daily living and limb motor function in stroke patients. Chin J Pract Nerv Dis. (2015) 18:1123.

  • 120.

    Yang Y . Application of neuromuscular electrical stimulation technology in the improvement of the quality of life of 40 cases of patients with cerebral apoplexy hemiplegia. Shanghai Med Pharm J. (2016) 37:403. doi: 10.3969/j.issn.2095-9664.2021.01.10

  • 121.

    Chen X Wang Y Wang J Wen H . Effect of neuromuscular electrical stimulation therapy on gait spatiotemporal parameters and symmetry indexes among hemiplegic patients with stroke. Acad J Guangzhou Med Univ. (2021) 49:3740. doi: 10.3969/j.issn.1000-8535.2021.06.021

  • 122.

    Chen Y . A randomized controlled study of the effects of four-channel FES on lower extremity motor function in stroke patients. Guangzhou Med J. (2021) 52:97100. doi: 10.3969/j.issn.1007-9572.2010.22.037

  • 123.

    Deng W . Effect of medium frequency pulse electrical stimulation combined with rehabilitation training in hemiplegic patients after cerebral infarction. Reflexol Rehabili Med. (2023) 4:5962.

  • 124.

    Sun L Zhang L Dong J . Effects of walking training assisted by electrical stimulation on motor recovery of the lower limb of stroke patients with foot drop. China J Mod Med. (2014) 24:825.

  • 125.

    Yu Y Zhao Y . The clinic study of electromyography-triggered neuromuscular stimulation in improving the lower extremity motor function of hemiplegia for stroke. Beijing Med J. (2010) 32:8046.

Summary

Keywords

electrical stimulation, lower limb function, network meta-analysis, randomized controlled trials, stroke

Citation

Liu J, Zeng F, Peng Z, Wen S, Liu D, Tang S and Su H (2026) Network meta-analysis of different electrical stimulation therapies for lower limb functional rehabilitation in stroke patients. Front. Neurol. 16:1682671. doi: 10.3389/fneur.2025.1682671

Received

09 August 2025

Revised

11 November 2025

Accepted

27 November 2025

Published

12 January 2026

Volume

16 - 2025

Edited by

Michele Romoli, Maurizio Bufalini Hospital, Italy

Reviewed by

Murat Mert, Istanbul Yeni Yüzyıl University, Türkiye

Kai Guo, Chinese Academy of Sciences (CAS), China

Updates

Copyright

*Correspondence: Huaxin Su,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics